Monday, March 3rd, 2008
International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease.
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...
Posted in Parkinson's Disease | No Comments »
Monday, March 3rd, 2008
Adult stem cells may provide an explanation for the cause of a Hutchinson-Gilford Progeria Syndrome (HGPS), a rare disease that causes premature aging in children, according to researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). These findings, the first to indicate a biological ...
Posted in Seniors / Aging | No Comments »
Tuesday, February 26th, 2008
The reductionist goal of cell biology is to explain cellular activities in physical-chemical terms. To do this, one needs to quantify molecular concentrations and aggregation states in living cells as they execute and regulate various complex processes.
For a complex cellular activity like migration, which is characterized by highly localized, transient ...
Posted in Medical Devices | No Comments »
Monday, February 25th, 2008
The energy from sunlight falling on only 9 percent of California's Mojave Desert could power all of the United States' electricity needs if the energy could be efficiently harvested, according to some estimates. Unfortunately, current-generation solar cell technologies are too expensive and inefficient for wide-scale commercial applications.
A team of Northwestern ...
Posted in Public Health | No Comments »
Monday, February 25th, 2008
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time a robust and highly efficient process for the generation of high-purity hepatocytes (liver cells). The research, described online (ahead of print) in the journal STEM CELLS, signifies a significant step towards the efficient generation of hepatocytes for use in ...
Posted in Stem Cell Research | No Comments »
Friday, February 22nd, 2008
Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) is pleased to announce favorable results from the investigator led BETAS (Beta-hCG + Erythropoietin in Acute Stroke), Phase IIa, open label, safety trial conducted at the University of California, Irvine and Hoag Presbyterian Memorial Hospital, Newport Beach, CA. This trial is the first ...
Posted in Stroke / Neuroprotection | No Comments »
Thursday, February 21st, 2008
Scientists at a US biotechnology company implanted immature beta-cells derived from human embryonic stem cells (hES cells) into mice and showed that they generated insulin-secreting cells that responded to raised blood sugar. They hope the discovery will one day lead to a renewable source of insulin-producing cells for the treatment ...
Posted in Diabetes | No Comments »
Wednesday, February 20th, 2008
For many patients, the pain and complications associated with sickle cell disease can have a profound impact on their quality of life, ability to work, and long-term health and well-being. Unfortunately, these challenges are often coupled with significant barriers to care. Hydroxyurea is an FDA-approved therapy for adults with certain ...
Posted in Blood / Hematology | No Comments »
Wednesday, February 20th, 2008
Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities, according to a new study by researchers at the Stanford University School of Medicine.
This study, to be published in the Feb. 20 issue of the ...
Posted in Stroke / Neuroprotection | No Comments »
